The Clinical Study of SHR-9839 for Injection in Patients With Advanced Solid Tumors

Summary

This study is an open-label, phase I clinical trial of SHR-9839 in patients with advanced solid tumors. The whole study is divided into three stages: dose escalation, dose expansion and efficacy expansion.

Timeline

Start

2023-05-18

Primary completion

2026-05-01

Completion

2026-06-01

Drugs

Indications